These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4056118)

  • 1. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
    Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
    Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etretinate on chemotaxis of neutrophils from patients with pustular and vulgar psoriasis.
    Pigatto PD; Riva F; Altomare GF; Brugo AM; Morandotti A; Finzi AF
    J Invest Dermatol; 1983 Nov; 81(5):418-9. PubMed ID: 6631053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Etretinate on the neutrophil chemotaxis in pustular psoriasis.
    Pigatto PD; Brugo AM; Finzi AF
    Boll Ist Sieroter Milan; 1982 May; 61(2):112-5. PubMed ID: 7126334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.
    Schopf RE; Höcher J; Rehder M; Färber L; Morsches B
    Arch Dermatol Res; 1992; 284(4):227-31. PubMed ID: 1417069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasis.
    Osada K; Seishima M; Mori S; Seishima M; Takemura M; Noma A
    Br J Dermatol; 1994 Nov; 131(5):655-9. PubMed ID: 7999596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.
    Ternowitz T
    J Am Acad Dermatol; 1987 Jun; 16(6):1169-75. PubMed ID: 3597858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
    Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
    Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased urinary polyamines in patients with psoriasis treated with etretinate.
    Grekin RC; Ellis CN; Goldstein NG; Swanson NA; Anderson TF; Duell EA; Voorhees JJ
    J Invest Dermatol; 1983 Mar; 80(3):181-4. PubMed ID: 6827127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration-stimulating effect of psoriatic scales on polymorphonuclear leukocytes.
    Lidén S; Bäck O; Pettersson A
    Arch Dermatol Res; 1980; 269(1):93-8. PubMed ID: 7447494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of retinoid (RO 10-9359) on chemotaxis and random migration of polymorphonuclear leucocytes in patients with pustulosis palmaris et plantaris].
    Aso K; Amano N
    Nihon Hifuka Gakkai Zasshi; 1983 Feb; 93(3):333-7. PubMed ID: 6348350
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.